Dynavax Technologies Corp’s recent filing unveils that its President & COO Novack David F unloaded Company’s shares for reported $0.14 million on Mar 24 ’25. In the deal valued at $14.00 per share,10,000 shares were sold. As a result of this transaction, Novack David F now holds 8,078 shares worth roughly $91200.62.
Then, DAVID NOVACK bought 10,000 shares, generating $140,000 in total proceeds.
Before that, Novack David F sold 14,020 shares. Dynavax Technologies Corp shares valued at $190,392 were divested by the President & COO at a price of $13.58 per share. As a result of the transaction, Novack David F now holds 8,078 shares, worth roughly $91200.62.
Goldman downgraded its Dynavax Technologies Corp [DVAX] rating to a Sell from a a Neutral in a research note published on February 11, 2025; the price target was decreased to $12 from $15. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in early February with a ‘”a Neutral”‘ rating. JMP Securities began covering DVAX with “Mkt outperform” recommendation on September 27, 2022.
Price Performance Review of DVAX
On Monday, Dynavax Technologies Corp [NASDAQ:DVAX] saw its stock fall -0.62% to $11.29. Over the last five days, the stock has gained 3.20%. Dynavax Technologies Corp shares have risen nearly 0.80% since the year began. Nevertheless, the stocks have fallen -11.59% over the past one year. While a 52-week high of $14.63 was reached on 03/07/25, a 52-week low of $9.22 was recorded on 05/14/25.
Levels Of Support And Resistance For DVAX Stock
The 24-hour chart illustrates a support level at 11.23, which if violated will result in even more drops to 11.17. On the upside, there is a resistance level at 11.39. A further resistance level may holdings at 11.49.
How much short interest is there in Dynavax Technologies Corp?
A steep rise in short interest was recorded in Dynavax Technologies Corp stocks on 2025-07-15, dropping by 11350.0 shares to a total of 15.16 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 15.17 million shares. There was a decline of -0.07%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 06, 2021 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $19 price target.
